Review



rabbit anti pd l1 antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Bioss rabbit anti pd l1 antibody
    The inhibitory effect of oxymatrine on liver cancer-bearing mice. Mice in the treatment group were injected with 100 mg/mL of oxymatrine and 200 μg of <t>anti-PD-L1.</t> ( A ) Representative images of HCC xenografts. Xenograft tumors were measured (n=4). ( B ) Tumor growth curve (n=4). ( C ) Tumor weight (n=4). ( D ) Changes in mouse body weight (n=4). ( E ) Representative images of tumor tissues stained with H&E (n=4). Scale bar, 100 μm. ( F ) ELISA detection of IFN-γ expression in mouse peripheral blood of the normal and xenograft model groups (n=4). ( G ) Immunohistochemical detection of CD8 + T and CD4 + T cell infiltration in tumor tissues (n=4). ( H and I ) Quantitative bar charts of the relative expressions of positive CD8 + T and CD4 + T cells in tumor tissues (n=4). ( J ) Western blotting detection (n=4) and ( K ) Bar charts of PD-L1, xCT, and GPX4 protein levels in xenografts (n=4). ns, no statistical difference; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Rabbit Anti Pd L1 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti pd l1 antibody/product/Bioss
    Average 93 stars, based on 2 article reviews
    rabbit anti pd l1 antibody - by Bioz Stars, 2026-02
    93/100 stars

    Images

    1) Product Images from "Oxymatrine Inhibits PD-L1 by Downregulating IFN-γ to Promote Ferroptosis and Enhance Anti-PD-L1 Efficacy in Liver Cancer"

    Article Title: Oxymatrine Inhibits PD-L1 by Downregulating IFN-γ to Promote Ferroptosis and Enhance Anti-PD-L1 Efficacy in Liver Cancer

    Journal: Journal of Hepatocellular Carcinoma

    doi: 10.2147/JHC.S492582

    The inhibitory effect of oxymatrine on liver cancer-bearing mice. Mice in the treatment group were injected with 100 mg/mL of oxymatrine and 200 μg of anti-PD-L1. ( A ) Representative images of HCC xenografts. Xenograft tumors were measured (n=4). ( B ) Tumor growth curve (n=4). ( C ) Tumor weight (n=4). ( D ) Changes in mouse body weight (n=4). ( E ) Representative images of tumor tissues stained with H&E (n=4). Scale bar, 100 μm. ( F ) ELISA detection of IFN-γ expression in mouse peripheral blood of the normal and xenograft model groups (n=4). ( G ) Immunohistochemical detection of CD8 + T and CD4 + T cell infiltration in tumor tissues (n=4). ( H and I ) Quantitative bar charts of the relative expressions of positive CD8 + T and CD4 + T cells in tumor tissues (n=4). ( J ) Western blotting detection (n=4) and ( K ) Bar charts of PD-L1, xCT, and GPX4 protein levels in xenografts (n=4). ns, no statistical difference; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.
    Figure Legend Snippet: The inhibitory effect of oxymatrine on liver cancer-bearing mice. Mice in the treatment group were injected with 100 mg/mL of oxymatrine and 200 μg of anti-PD-L1. ( A ) Representative images of HCC xenografts. Xenograft tumors were measured (n=4). ( B ) Tumor growth curve (n=4). ( C ) Tumor weight (n=4). ( D ) Changes in mouse body weight (n=4). ( E ) Representative images of tumor tissues stained with H&E (n=4). Scale bar, 100 μm. ( F ) ELISA detection of IFN-γ expression in mouse peripheral blood of the normal and xenograft model groups (n=4). ( G ) Immunohistochemical detection of CD8 + T and CD4 + T cell infiltration in tumor tissues (n=4). ( H and I ) Quantitative bar charts of the relative expressions of positive CD8 + T and CD4 + T cells in tumor tissues (n=4). ( J ) Western blotting detection (n=4) and ( K ) Bar charts of PD-L1, xCT, and GPX4 protein levels in xenografts (n=4). ns, no statistical difference; * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

    Techniques Used: Injection, Staining, Enzyme-linked Immunosorbent Assay, Expressing, Immunohistochemical staining, Western Blot

    IFN-γ’s effect on the expressions of PD-L1 protein in liver cancer cell lines. ( A-C ) Western blotting detection of PD-L1 protein level in HEPG2, MHCC97H, and H22 cells after 24-h intervention with IFN-γ (0, 5, 10, 20, and 40 ng/mL) (left), and bar charts of PD-L1 relative expression (right) (n=3). ns, no statistical difference; * P < 0.05; ** P < 0.01.
    Figure Legend Snippet: IFN-γ’s effect on the expressions of PD-L1 protein in liver cancer cell lines. ( A-C ) Western blotting detection of PD-L1 protein level in HEPG2, MHCC97H, and H22 cells after 24-h intervention with IFN-γ (0, 5, 10, 20, and 40 ng/mL) (left), and bar charts of PD-L1 relative expression (right) (n=3). ns, no statistical difference; * P < 0.05; ** P < 0.01.

    Techniques Used: Western Blot, Expressing



    Similar Products

    Image Search Results